Grifols S.A. (GRFS) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Grifols S.A. (GRFS)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

7.10

-0.13 (-1.80%)

At close: Jan 14, 2025, 3:59 PM

7.07

-0.42%

Pre-market Jan 15, 2025, 04:06 AM EST

undefined% (undefined)

Bid	7.14
Market Cap	5.66B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	0.25
PE Ratio (ttm)	28.4
Forward PE	n/a
Analyst	Sell

Ask	7.19
Volume	698,401
Avg. Volume (20D)	1,001,214
Open	7.25
Previous Close	7.23
Day's Range	7.00 - 7.28
52-Week Range	5.30 - 9.96
Beta	undefined

About GRFS

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunogl...

[Show more]

Industry Drug Manufacturers - General

Sector Healthcare

IPO Date Jun 2, 2011

Employees 23,000

Stock Exchange NASDAQ

Ticker Symbol GRFS

Website https://www.grifols.com

Analyst Forecast

According to 2 analyst ratings, the average rating for GRFS stock is "Sell." The 12-month stock price forecast is $10.5, which is an increase of 47.89% from the latest price.

Buy 0.00%

Hold 50.00%

Sell 50.00%

Stock Forecasts

Why Price Moved

1 month ago · Source

Grifols shares are trading lower after the company... Unlock content with Pro Subscription

2 months ago · Source

+5.06%

Grifols shares are trading higher following a report suggesting banks are preparing to submit final offers for a buyout debt deal.

News

2 days ago · reuters.com

Mason Capital complains about Grifols' transparency to Spanish regulator

U.S.-based investment fund Mason Capital said on Monday it had sent a letter to Spain's stock market regulator CNMV demanding more transparency from the embattled pharmaceutical company Grifols.

2 days ago · businesswire.com

Mason Capital Management Sends Letter to Spanish National Securities Market Commission Regarding Lack of Transparency by Grifols

NEW YORK--(BUSINESS WIRE)--Mason Capital Management LLC (“Mason”), a registered investment advisor to funds and accounts holding approximately 2.5% of Grifols S.A. (“Grifols” or the “Company”) (BME: G...

1 month ago · businesswire.com

Flat Footed Calls for Prompt Governance Overhaul at Grifols

BARCELONA, Spain--(BUSINESS WIRE)--Flat Footed LLC is the investment manager for FF Hybrid LP, Flat Footed Series LLC - Fund 3, and GP Recovery Fund LLC (collectively, with Flat Footed LLC, “Flat Foot...

1 month ago · businesswire.com

Mason Capital Management Requests Immediate Disclosure of Important Information Regarding Conflicted Grifols Director Tomas Daga

NEW YORK--(BUSINESS WIRE)--Mason Capital Management LLC (“Mason”), a registered investment advisor to funds and accounts holding approximately 2.1% of Grifols S.A. (“Grifols” or the “Company”) (BME: G...

1 month ago · businesswire.com

Statement From Araoz y Rueda on Behalf of Certain Institutional Investors in Grifols

MADRID--(BUSINESS WIRE)--Law firm Araoz y Rueda has been independently engaged by several international and Spanish institutions (the “Clients”) holding in aggregate 5.65% of A shares and 3.88% of B s...

1 month ago · seekingalpha.com

Grifols: More Attractive Than In A Very Long Time

I don't divest unless the fundamental thesis changes; Grifols' buyout offer from Brookfield Asset Management is undervalued, so I maintain my "Buy" stance. Despite Brookfield's offer, I believe Grifol...

1 month ago · benzinga.com

Why Is Spanish Healthcare Grifols Stock Trading Lower On Friday?

On Wednesday, Grifols SA GRFS said it ended discussions with Brookfield Capital Partners (UK) Limited about a potential acquisition.

1 month ago · zacks.com

Grifols Stock Declines After Brookfield Drops Buyout Offer

Brookfield decides to drop its buyout offer for GRFS following discrepancies over the company's valuation.

1 month ago · reuters.com

Grifols shares tumble after report on Brookfield abandoning takeover plan

Shares in Grifols were falling on Wednesday morning after Bloomberg reported Canadian fund Brookfield is considering dropping its plan to take over the Spanish pharmaceutical firm.

1 month ago · zacks.com

Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%

Per GRFS, Brookfield's offer to buy its entire outstanding share capital for 6.45 billion euros significantly undervalues GRFS' prospects and long-term potential.

1 month ago · reuters.com

Grifols: Brookfields potential $6.8 bln offer undervalues the firm

Grifols said on Tuesday that Canadian investment fund Brookfield's potential 6.45 billion euro ($6.8 billion) offer significantly undervalued the Spanish drugmaker's prospects and long-term potential.

1 month ago · reuters.com

Spanish court opens investigation into Gotham City's attack on Grifols

An investigating magistrate at the Spanish High Court said on Tuesday it had opened an investigation into U.S.-based short seller Gotham City's actions that brought down the share price of Spanish pha...

1 month ago · businesswire.com

Mason Capital Reiterates Corporate Governance Shortcomings and Mismanagement of Grifols Under Current Board of Directors

1 month ago · reuters.com

Brookfield mulls $7.4 bln bid for Spain's Grifols, El Confidencial says

Canadian fund Brookfield plans to offer about 7 billion euros ($7.4 billion) for Spanish drugmaker Grifols after finishing due diligence, news website El Confidencial reported on Monday, citing source...

2 months ago · businesswire.com

Mason Capital Management Highlights Corporate Governance Failures and Significant Shareholder Value Destruction Under Grifols Board of Directors

2 months ago · reuters.com

Grifols on track to meet 2024 targets despite third-quarter profit drop

Spanish drugmaker Grifols said on Thursday it was on track to meet its targets for the year after its net profit fell 7.5% in the third quarter from the same period a year ago.